2024-06-27T11:03:18-07:00 2023-08-31 990 2022-09-01 203674498 GLOBAL HEALTH SOLUTIONS INC GLOB 4045921430 330 W Ponce de Leon Ave Decatur GA 300303001 Ellen Wild Chief Operating Officer 4046875607 2024-02-28 Ellen Wild 999009999 1 1 11 1 AAL2 X 2022 2023-04-26 12:10:37Z Ellen Wild 330 West Ponce de Leon Ave Decatur GA 30030 628809066 0 X www.taskforce.org X 2005 GA As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc. 4 0 0 0 0 0 632371996 628809066 0 0 0 0 0 0 632371996 628809066 632371996 628809066 0 0 0 0 0 0 0 0 0 632371996 628809066 0 0 0 0 0 0 0 0 As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases. 0 0 56375444 0 56375444 In 2023, over 376 million treatments were approved for river blindness and LF elimination-a modest increase from 2022 when 364 million treatments were approved. This includes nearly 58 million treatments approved for the implementation of "triple therapy" in 12 countries. So far, Merck has shipped Mectizan to 22 countries and territories to facilitate the implementation of IDA to accelerate the elimination of LF in countries where river blindness is not endemic. As of the end of 2023, cumulatively, more than 5.5 billion Mectizan treatments have been approved by the Mectizan Donation Program, and more than 13 billion tablets have been shipped to 58 endemic countries by Merck since the donation was announced in 1987. In 2023, progress was reported for both diseases. For river blindness, 47 million no longer need treatment in 13 countries; for LF, over 305 million no longer need treatment in 20 countries. The Mectizan Donation Program and its partners are on track to meet the elimination targets established by the World Health Organization's 2021-2030 Neglected Tropical Disease Road Map to eliminate onchocerciasis in 12 countries and lymphatic filariasis in 58 countries. 572433622 0 572433622 The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma, even in the midst of a global pandemic. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of Zithromax(R) to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2022 and August 2023, ITI organized just-in-time shipments of 41.5 million treatments for trachoma to be distributed at MDAs in 15 countries. As of August 2023, ITI has shipped more than 1.022 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 3,700 surveys across 52 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 115.7 million in April 2023 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality. 0 0 0 628809066 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 4 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 GA X X Daniel N Martins 4046875620 330 W Ponce de Leon Ave Decatur GA 300303001 David A Ross Chairman 1 39 X 0 0 417725 Patrick O'Carroll Chairman 1 39 X 0 0 357404 Mark McKinlay Officer 1 39 X 0 0 341085 William P Nichols Treasurer 1 39 X 0 0 322266 Ellen Wild Officer 1 39 X 0 0 206634 0 0 1645114 0 1 1 1 0 0 0 0 0 0 628809066 628809066 628809066 0 0 0 0 0 0 0 628809066 0 0 0 0 0 0 0 628809066 628809066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 628809066 628809066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 1 X 1 0 X X X 1 THE TASK FORCE FOR GLOBAL HEALTH INC Type I 581698648 7 1 0 628809066 1 0 628809066 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 628809066 0 0 0 0 0 628809066 0 0 0 628809066 628809066 0 0 0 0 0 628809066 0 0 0 628809066 Schedule D, Part VI, Line 1a The Organization does not own any assets and does not owe any liabilities and so does not have a balance sheet. 1 Central America and the Caribbean 0 0 Program Services Donated mectizan drugs for treatment 41160 East Asia and the Pacific 0 0 Program Services Donated mectizan and zithromax drugs for treatments 2514393 Middle East and North Africa 0 0 Program Services Donated mectizan and zithromax drugs for treatments 17130024 South Asia 0 0 Program Services Donated mectizan drugs for treatments 34592880 Sub-Saharan Africa 0 0 Program Services Donated mectizan and zithromax drugs for treatments 574530609 0 0 628809066 Central America and the Caribbean Treatment of onchocerciasis in Haiti 0 N/A 41160 Donated mectizan drugs Lower of donor's or market value East Asia and the Pacific Treatment for onchocerciasis and trachoma 0 N/A 2514394 Donated mectizan and zithromax drugs Lower of donor's or market value Middle East and North Africa Treatment for onchocerciasis and trachoma 0 N/A 17130025 Donated mectizan and zithromax drugs Lower of donor's or market value South Asia Treatment for onchocerciasis and trachoma 0 N/A 34592880 Donated mectizan and zithromax drugs Lower of donor's or market value Sub-Saharan Africa Treatment for onchocerciasis and trachoma 0 N/A 574530609 Donated mectizan and zithromax drugs Lower of donor's or market value 34 0 0 0 0 0 0 1 Schedule F, Part I, Line 2 The In-Kind Contributions are shipped directly by the donors to the countries where they are needed. Global Health Solutions obtains the shipping documents for processing in the accounting system. Occasional site visits are carried out in some countries to assess and evaluate the impact of the program activities. In our Ethiopia country office, an audit firm is appointed to ensure that things are done in compliance to required rules and regulations. 0 0 0 0 0 0 0 0 0 David A Ross Chairman 0 380847 0 0 0 0 0 23444 0 13434 0 417725 0 0 Patrick O'Carroll Chairman 0 328667 0 0 0 0 0 27450 0 1287 0 357404 0 0 William P Nichols Treasurer 0 295269 0 0 0 0 0 25833 0 1164 0 322266 0 0 Ellen Wild Officer 0 188520 0 0 0 0 0 17073 0 1041 0 206634 0 0 Mark McKinlay Officer 0 301101 0 0 0 0 0 25207 0 14777 0 341085 0 0 Schedule J, Part I, Line 3 The organization does not have employees but has officers who are paid by the related organization X 2 628809066 Lower of cost or donor's cost 0 1 0 Schedule M, Part I, Line 32b Drugs donated are shipped by third parties Form 990, Part VI, Section B, Line 11b Once Form 990 is completed, it is emailed as a pdf file to each board member and officers for their review and comments. They are to notify the organization within five business days with any issues or concerns Form 990, Part VI, Section B, Line 12c The organization does not have employees but has officers. At the end of every fiscal year, all officers are required to read and sign all relevant policies. Form 990, Part VI, Section C, Line 19 The financial information for three fiscal years is available on the organization's website together with its Form 990 reports and conflict of interest policy The Task Force for Global Health Inc 330 W Ponce de Leon Ave Decatur GA 30030 581698648 Management and distribution of donated medicines GA 501(c)(3) 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 The Task Force for Global Health Inc n 12000 Global Health Solutions, Inc. uses the office space and equipments of The Task Force for Global Health, Inc. for its operations. Office space is estimated at $12,000 ( 4 office spaces @ $250/mth each)